+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 56 Pages
  • June 2022
  • GlobalData
  • ID: 2081860
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Tecan Group Ltd (TECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions
  • Corporate strategy - Analyst’s summarization of the company’s business strategy
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
  • Company history - Progression of key events associated with the company
  • Major products and services - A list of major products, services and brands of the company
  • Key competitors - A list of key competitors to the company
  • Key employees - A list of the key executives of the company
  • Executive biographies - A brief summary of the executives’ employment history
  • Key operational heads - A list of personnel heading key departments/functions
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history

Highlights

Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find application in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions, and synthetic biology. Its systems and components are used widely in clinical diagnostics and basic and translational research. The company operates manufacturing and research facilities in Europe and North America. Tecan is headquartered in Mannedorf, Switzerland.

Tecan Group Ltd Key Recent Developments

Apr 12, 2022: Tecan announce Annual General Meeting 2022
Mar 15, 2022: Tecan closes transformative year with substantial growth in sales and net profit
Dec 16, 2021: Myra Eskes to be proposed to the upcoming Annual General Meeting as a new member of Tecan’s Board of Directors
Jun 24, 2021: Tecan Group to acquire medical devices manufacturer Paramit for $1bn
Apr 13, 2021: Annual General Meeting 2021: Tecan shareholders endorse all motions proposed by the Board of Directors

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Tecan Group Ltd - Key Facts
  • Tecan Group Ltd - Key Employees
  • Tecan Group Ltd - Key Employee Biographies
  • Tecan Group Ltd - Major Products and Services
  • Tecan Group Ltd - History
  • Tecan Group Ltd - Company Statement
  • Tecan Group Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Tecan Group Ltd - Business Description
  • Business Segment: Life Sciences
  • Overview
  • Performance
  • Business Segment: Partnering Business
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Others
  • Performance
  • R&D Overview
  • Tecan Group Ltd - Corporate Strategy
  • Tecan Group Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Tecan Group Ltd - Strengths
  • Tecan Group Ltd - Weaknesses
  • Tecan Group Ltd - Opportunities
  • Tecan Group Ltd - Threats
  • Tecan Group Ltd - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Tecan Group Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Tecan Group Ltd, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Tecan Group Ltd, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Apr 12, 2022: Tecan announce Annual General Meeting 2022
  • Mar 15, 2022: Tecan closes transformative year with substantial growth in sales and net profit
  • Dec 16, 2021: Myra Eskes to be proposed to the upcoming Annual General Meeting as a new member of Tecan’s Board of Directors
  • Apr 13, 2021: Annual General Meeting 2021: Tecan shareholders endorse all motions proposed by the Board of Directors
  • Mar 16, 2021: Tecan reports significant growth in sales and profits in 2020 based on extraordinary demand for COVID-19 related products
  • Mar 09, 2021: Tecan schedules conference call on March 16 to discuss Full-Year 2020 Financial Results

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • Tecan Group Ltd, Key Facts
  • Tecan Group Ltd, Key Employees
  • Tecan Group Ltd, Key Employee Biographies
  • Tecan Group Ltd, Major Products and Services
  • Tecan Group Ltd, History
  • Tecan Group Ltd, Subsidiaries
  • Tecan Group Ltd, Key Competitors
  • Tecan Group Ltd, Ratios based on current share price
  • Tecan Group Ltd, Annual Ratios
  • Tecan Group Ltd, Interim Ratios
  • Tecan Group Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Tecan Group Ltd, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Tecan Group Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Tecan Group Ltd, Performance Chart (2017 - 2021)
  • Tecan Group Ltd, Ratio Charts
  • Tecan Group Ltd, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Tecan Group Ltd, Medical Equipment, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Qiagen NV
  • 4basebio AG
  • Vifor Pharma Ltd
  • BioTek Instruments Inc
  • Sonova Holding AG
  • Buchi Labortechnik AG